bg
A

Allakos (ALLK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allakos (ALLK)

Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more

  • USD1.43
  • USD1.46
  • USD1.36
  • USD5.64
  • 35.80%
  • --
  • 468.82k
  • 450.29k
  • 106M
  • 0.98
  • -71.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.